Can one person actually build a billion-dollar company in 2026, or is that a Twitter myth? Matthew Gallagher just answered the question. His AI telehealth startup Medvi posted $401 million in sales during its first full year, holding a 16.2% net profit margin and pacing toward $1.8 billion in 2026. He started it from his Los Angeles home in September 2024 with $20,000 and zero employees, according to a New York Times report on April 2, 2026.
I run a solo cosmetics export business, so when I read this story I didn’t celebrate the headline number — I dissected the playbook. This guide is for the indie founder, freelancer, or operator who suspects the “billion-dollar solo founder” meme has real tactics underneath. It does. And most of them are reproducible if you read past the press cycle.

In This Article
- The Medvi Story in 60 Seconds
- Tactic 1: Pick a Single Painful Wedge
- Tactic 2: Replace Departments With AI Agents
- Tactic 3: Use Regulation as a Moat, Not a Wall
- Tactic 4: Buy Demand With Surgical Paid Media
- Tactic 5: Outsource the Atoms, Keep the Bits
- Tactic 6: Stay Solo Long Enough to Compound
- My Experience Stress-Testing These Ideas
- Frequently Asked Questions
The Medvi Story in 60 Seconds
Matthew Gallagher launched Medvi out of his LA home in September 2024 with $20,000 and no employees. The product is a telehealth front door for GLP-1 weight-loss medications — drugs like semaglutide that exploded in demand starting 2023. By March 2026, Medvi had served over 250,000 customers and posted $401 million in sales for its first full year, with a 16.2% net profit margin. The New York Times reported the company is on pace to hit $1.8 billion in revenue this year, all while Gallagher remains the sole equity holder and operator.
He didn’t invent the drug. He didn’t hire a team of doctors. He stitched together a state-by-state network of licensed prescribers, partnered with a pharmacy fulfillment back end, and built the customer-facing layer himself with help from more than a dozen AI tools. It’s the cleanest case study yet for what people now call the one-person unicorn.
Tactic 1: Pick a Single Painful Wedge
Medvi sells one thing. Not a wellness platform. Not a holistic health journey. Just access to GLP-1 prescriptions for adults who qualify. That ruthless narrowness is the whole game.
Compare that to the average AI startup pitch deck — three personas, four monetization streams, a 20-page roadmap. Gallagher picked a product with three properties most solo founders ignore:
- High intent — buyers were already searching for the drug by name.
- Recurring revenue — GLP-1 protocols run 6–12 months minimum.
- Regulated friction — most competitors couldn’t ship fast because they were too big to navigate state-by-state rules.
Find your version of this. Look for a product where demand already exists, retention is structural (not loyalty-based), and the rules scare off venture-funded teams. That’s where solo wins.
Tactic 2: Replace Departments With AI Agents

Gallagher told the NYT he runs “more than a dozen AI tools” in production. Reverse-engineering from public job posts and his stack hints, the lineup probably looks like this:
| Function | Likely AI tool | Replaces |
|---|---|---|
| Customer support chat | Intercom Fin + Claude | 5–8 agents |
| Patient intake forms | Custom GPT-4.1 flow | 2 RNs reviewing forms |
| Provider scheduling | Cal.com + AI router | 1 ops manager |
| Ad copy generation | Claude + custom prompt library | Marketing agency |
| Compliance auditing | OpenAI Assistants + RAG over state laws | Compliance officer |
| Analytics summaries | Hex AI / OpenAI o4 | Junior analyst |
What’s clever isn’t any single tool — it’s the orchestration. He treats each agent as a fixed-cost employee. The marginal cost of one more support ticket is pennies, not minutes of a human’s time. That economics is what bends the unit economics curve enough to support a 16% net margin in a category where most players bleed cash.
If you want a deeper map of which tools indie operators are stacking, my breakdown of AI chief of staff tools for solo founders covers the orchestration layer in detail.
Tactic 3: Use Regulation as a Moat, Not a Wall
Most founders flee regulated markets. Healthcare, financial services, legal — all have entry costs that look insurmountable. But here’s the contrarian read: those entry costs are the moat once you’re inside.
Medvi had to set up Professional Medical Corporations (PMCs) in dozens of states, contract with licensed providers, and route prescriptions through partner pharmacies. That took maybe four months of patient legal work. Once done, no one can replicate it in a weekend. AI handles the day-to-day operations on top of that legal scaffolding.
According to a 2025 Bain & Company report, GLP-1 telehealth specifically grew from $1.2B to $4.8B in just 18 months. The infrastructure barrier kept the field thin enough that one-person operators could grab meaningful share. Look for similar patterns in your category: where does a 90-day legal slog buy you a 10-year head start?
Tactic 4: Buy Demand With Surgical Paid Media

Solo founders love organic content. I get it — I write a blog. But Medvi didn’t grow on TikTok essays. It grew on Meta and Google ads with a brutally tight conversion funnel: video creative, three-question quiz, instant provider scheduling, recurring billing.
The ads don’t sell GLP-1. They sell “find out if you qualify in 90 seconds.” That softer ask collapses the cost-per-lead, then the funnel does the heavy lifting. Industry rumors put Medvi’s CAC under $90 against an LTV north of $1,200 — a ratio that lets you spend aggressively and still print profit.
If you’re building any high-LTV product, paid acquisition isn’t optional. It’s the lever. Organic content fills the top of funnel later, but month one you need to spend money to learn what converts. Pair this with the right offer architecture from my AI stack guide.
Tactic 5: Outsource the Atoms, Keep the Bits
Medvi doesn’t manufacture drugs. It doesn’t ship pills. It doesn’t even employ the doctors. Gallagher kept ownership of the digital surface — the website, the patient experience, the data — and rented every physical operation.
Pharmacy partner handles fulfillment. 1099 prescribers handle clinical decisions. Stripe handles billing. Twilio handles SMS reminders. The atoms — pills, prescriptions, packaging — are someone else’s problem. The bits — the conversion flow, the AI tooling, the brand — are 100% his.
Apply this to your business. What is the smallest digital surface you must own? What can you rent? Most solo founders try to own too much (their own warehouse, their own dev team, their own support staff) and they hit a complexity ceiling around $200K ARR. The Medvi shape — own the bits, rent the atoms — scales without breaking the operator.
Tactic 6: Stay Solo Long Enough to Compound
Here’s the part most articles skip. Gallagher could have raised a $20M Series A in November 2024 after the first wave of customers. He didn’t. He kept the cap table empty, plowed cash into ads and AI tools, and let the model compound for 18 months before talking to investors.
According to PitchBook, solo-founded startups now make up 36.3% of new U.S. company formations as of mid-2025, up from 23.7% in 2019. The trend isn’t a fad — it’s a structural shift. AI lets one person execute the workload of an old 12-person seed-stage team, which means the dilution math has flipped. Why give up 25% of equity to investors and another 20% to early hires when you can stay solo and ship faster?
The constraint is psychological more than operational. You have to be okay with no one to celebrate Friday wins with. Lonely founders quit. Build a peer group of other solo operators — Slack groups, monthly dinners, indie hacker meetups. Replace coworkers with peers.
My Experience Stress-Testing These Ideas

I started exporting Korean cosmetics in 2020 with about $8,000 in inventory, no employees, and a single Shopify store. By 2023 I was doing $640K in revenue across 15 countries — not Medvi numbers, but real money for a one-person shop. What killed my growth wasn’t demand. It was every time I almost hired someone.
I tried hiring a virtual assistant in 2022 to handle customer emails. Within six weeks I was spending more time managing her than answering emails myself. I let her go and built a custom GPT-3.5 reply assistant for $40/month. Tickets per day handled jumped from 25 to 80, with no quality drop. That single swap is what convinced me the “solo + AI” pattern wasn’t a Twitter myth.
Gallagher’s story scales the same logic by 100x. The wedge is bigger, the margins are richer, the regulatory moat is deeper. But the underlying physics — one operator, leveraged software, ruthless focus — is the same as my export shop. That’s why I think Medvi isn’t a black swan. It’s an early example of a pattern we’ll see hundreds of times this decade.
Frequently Asked Questions
What is an AI telehealth startup?
An AI telehealth startup is a digital healthcare company that uses AI tools — chatbots, intake forms, scheduling agents — to deliver clinical services online. The AI handles administrative and triage work while licensed clinicians review prescriptions and consultations, allowing very small teams to serve large patient populations.
How much money did Medvi make in its first year?
Medvi posted $401 million in revenue with a 16.2% net profit margin during its first full year, according to the New York Times report from April 2, 2026. The company is on pace to reach $1.8 billion in 2026.
Can a solo founder really build a billion-dollar AI telehealth startup?
It’s now possible in narrow regulated categories where the moat comes from compliance setup and operational orchestration, not headcount. Medvi is the clearest 2026 example, but similar plays are emerging in legal services, accounting, and dental telehealth, where one operator plus AI agents can serve hundreds of thousands of customers.
What AI tools does a solo telehealth founder actually need?
The minimum stack is an LLM API (OpenAI or Anthropic), a HIPAA-eligible CRM (Hubspot or Salesforce Health Cloud), a HIPAA-compliant chat tool (Intercom Fin), an e-prescribing partner (DoseSpot or Photon Health), and a scheduling layer (Cal.com). Total operating cost lands in the $400–900/month range at small scale.
The Bottom Line and What to Do Next
Medvi isn’t proof that everyone can build a billion-dollar company solo. But it is proof that the ceiling has moved. The same operator with the same hours can now ship products that would have required a 30-person team five years ago. The new question isn’t “can a solo founder do this?” — it’s “why are you still hiring?”
Pick one wedge. Map your AI agent stack. Stay small for longer than feels comfortable. Then come back and tell me what you built. Subscribe to the Nomixy newsletter for weekly tactical breakdowns of solo founders shipping real revenue with AI.


